Strategic CEO - Antifibrotic Drug Leader

A biopharmaceutical company is seeking a CEO to lead the strategic vision, drive clinical milestones, and secure funding for the TG2 inhibitor. The ideal candidate will have strong leadership skills, experience in investor relations, and a solid understanding of clinical trial processes. This role includes overseeing Phase 1 trials and building a high-performing team, essential for navigating the antifibrotic market. The company requires strategic insight to enhance its presence and overcome regulatory challenges.